Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8026247 Bicyclic amides as kinase inhibitors

Patent 8026247 was granted and assigned to Novartis on September, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andreas Floersheimer0

Andrea Vaupel0

Giorgio Caravatti0

Guido Bold0

Hans-Georg Capraro0

Pascal Furet0

Paul W. Manley0

Date of Patent

September 27, 2011

0

Patent Application Number

115750250

Date Filed

September 14, 2005

0

Patent Citations Received

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

0

US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

0

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

0

Patent Primary Examiner

Kahsay T. Habte

0

Patent abstract

The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8026247 Bicyclic amides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool